Literature DB >> 11805432

Decreased tubular uptake of L-3,4-dihydroxyphenylalanine in streptozotocin-induced diabetic rats.

A Carranza1, L Karabatas, M Barontini, I Armando.   

Abstract

BACKGROUND/AIMS: This study determined alterations in renal dopamine production in streptozotocin-treated rats and explored the mechanisms underlying this alteration.
METHODS: Streptozotocin (65 mg/kg) or vehicle was administered to 3-month-old male Wistar rats. Treated animals had hyperglycemia, glycosuria and increased diuresis, natriuresis and excretion of L-dopa. Urinary dopamine and dihydroxyphenylacetic acid were similar to those in control animals. The production of dopamine by renal cortex slices from treated rats was significantly less than that from control animals. The addition of glucose (8.4-18.4 mM) to the incubation medium decreased about 40% the uptake of L-dopa by isolated proximal tubular cells. Scatchard analysis of the saturation curves obtained in this condition showed a decrease in the V(max) without changes in the K(m).
RESULTS: Our results confirm previous studies suggesting a renal dopaminergic deficiency in insulin-dependent diabetes and provide evidence strongly suggesting that a decrease in the number of tubular L-dopa transport sites is the underlying defect of this deficiency.
CONCLUSION: These results highlight the role of the uptake of dopa as an important modulator of renal dopamine synthesis. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11805432     DOI: 10.1159/000050014

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  8 in total

1.  Insulin enhances L-dopa renal proximal tubule uptake: a regulatory mechanism impaired in insulin resistance.

Authors:  Andrea Carranza; Carlos F Mendez; Marta Barontini; Susana Nowicki
Journal:  Pflugers Arch       Date:  2004-02-12       Impact factor: 3.657

Review 2.  Renal dopaminergic system: Pathophysiological implications and clinical perspectives.

Authors:  Marcelo Roberto Choi; Nicolás Martín Kouyoumdzian; Natalia Lucía Rukavina Mikusic; María Cecilia Kravetz; María Inés Rosón; Martín Rodríguez Fermepin; Belisario Enrique Fernández
Journal:  World J Nephrol       Date:  2015-05-06

3.  Regulation of renalase expression by D5 dopamine receptors in rat renal proximal tubule cells.

Authors:  Shaoxiong Wang; Xi Lu; Jian Yang; Hongyong Wang; CaiYu Chen; Yu Han; Hongmei Ren; Shuo Zheng; Duofen He; Lin Zhou; Laureano D Asico; Wei Eric Wang; Pedro A Jose; Chunyu Zeng
Journal:  Am J Physiol Renal Physiol       Date:  2014-02-05

4.  Effect of dopamine D3 receptor blockade on renal function and glomerular size in diabetic rats.

Authors:  Gerd Luippold; Martina Beilharz; Manfred Wehrmann; Liliane Unger; Gerhard Gross; Bernd Mühlbauer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-05-11       Impact factor: 3.000

5.  Kidney dopamine D1-like receptors and angiotensin 1-7 interaction inhibits renal Na+ transporters.

Authors:  Anees A Banday; Andrea Diaz Diaz; Mustafa Lokhandwala
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-14

6.  Gastrin stimulates renal dopamine production by increasing the renal tubular uptake of l-DOPA.

Authors:  Xiaoliang Jiang; Yanrong Zhang; Yu Yang; Jian Yang; Laureano D Asico; Wei Chen; Robin A Felder; Ines Armando; Pedro A Jose; Zhiwei Yang
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-10-25       Impact factor: 4.310

7.  Intrarenal dopamine inhibits progression of diabetic nephropathy.

Authors:  Ming-Zhi Zhang; Bing Yao; Shilin Yang; Haichun Yang; Suwan Wang; Xiaofeng Fan; Huiyong Yin; Agnes B Fogo; Gilbert W Moeckel; Raymond C Harris
Journal:  Diabetes       Date:  2012-06-11       Impact factor: 9.461

8.  Atrial Natriuretic Peptide Stimulates Dopamine Tubular Transport by Organic Cation Transporters: A Novel Mechanism to Enhance Renal Sodium Excretion.

Authors:  Nicolás M Kouyoumdzian; Natalia L Rukavina Mikusic; María C Kravetz; Brenda M Lee; Andrea Carranza; Julieta S Del Mauro; Marcela Pandolfo; Mariela M Gironacci; Susana Gorzalczany; Jorge E Toblli; Belisario E Fernández; Marcelo R Choi
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.